BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Z, Wang Y. miR-96 targets SOX6 and promotes proliferation, migration, and invasion of hepatocellular carcinoma. Biochem Cell Biol 2018;96:365-71. [DOI: 10.1139/bcb-2017-0183] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Cao X, Zhang J, Apaer S, Yao G, Li T. microRNA-19a-3p and microRNA-376c-3p Promote Hepatocellular Carcinoma Progression Through SOX6-Mediated Wnt/β-Catenin Signaling Pathway. Int J Gen Med 2021;14:89-102. [PMID: 33469348 DOI: 10.2147/IJGM.S278538] [Reference Citation Analysis]
2 Liu B, Zhang J, Yang D. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1. J Ovarian Res 2019;12:57. [PMID: 31228941 DOI: 10.1186/s13048-019-0533-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
3 Fodor A, Lazar AL, Buchman C, Tiperciuc B, Orasan OH, Cozma A. MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis. Int J Mol Sci 2021;22:6337. [PMID: 34199293 DOI: 10.3390/ijms22126337] [Reference Citation Analysis]
4 Zhou C, Hu C, Wang B, Fan S, Jin W. Curcumin Suppresses Cell Proliferation, Migration, and Invasion Through Modulating miR-21-5p/SOX6 Axis in Hepatocellular Carcinoma. Cancer Biother Radiopharm 2020. [PMID: 32757994 DOI: 10.1089/cbr.2020.3734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Yang S, Chen Z, Fan D, Zhang R, Zhang Y, Wu S. Retracted Article: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3. RSC Adv 2018;8:34973-83. [DOI: 10.1039/c8ra07055e] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Shi Y, Han Y, Niu L, Li J, Chen Y. MiR-499 inhibited hypoxia/reoxygenation induced cardiomyocytes injury by targeting SOX6. Biotechnol Lett 2019;41:837-47. [PMID: 31076992 DOI: 10.1007/s10529-019-02685-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
7 Saleem M, Rahman S, Elijovich F, Laffer CL, Ertuglu LA, Masenga SK, Kirabo A. Sox6, A Potential Target for MicroRNAs in Cardiometabolic Disease. Curr Hypertens Rep. [DOI: 10.1007/s11906-022-01175-8] [Reference Citation Analysis]
8 Huang Y, Zhang J, Li H, Peng H, Gu M, Wang H. miR-96 regulates liver tumor-initiating cells expansion by targeting TP53INP1 and predicts Sorafenib resistance. J Cancer 2020;11:6545-55. [PMID: 33046975 DOI: 10.7150/jca.48333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 He X, Zou K. MiRNA-96-5p contributed to the proliferation of gastric cancer cells by targeting FOXO3. J Biochem. 2019;pii:mvz080. [PMID: 31598681 DOI: 10.1093/jb/mvz080] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
10 Huang T, Fu Y, Wang S, Xu M, Yin X, Zhou M, Wang X, Chen C. miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation. Biomed Pharmacother 2019;119:109413. [PMID: 31518872 DOI: 10.1016/j.biopha.2019.109413] [Reference Citation Analysis]
11 Zhang L, Niu X, Zhang X, Zhan G, Xue X, Wang X, Zhang H, Guo Z. SRY-related high-mobility-group box 6 suppresses cell proliferation and is downregulated in breast cancer. Anticancer Drugs 2021;32:306-13. [PMID: 33038083 DOI: 10.1097/CAD.0000000000001004] [Reference Citation Analysis]
12 Xu T, Du XW, Hu JB, Zhu YF, Wu HL, Dai GP, Shu YM, Ouyang J. Anticancer effect of miR-96 inhibitor in bladder cancer cell lines. Oncol Lett 2018;15:3814-9. [PMID: 29467898 DOI: 10.3892/ol.2018.7745] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
13 Zhou T, Ren Z, Chen C. [METTL14 as a predictor of postoperative survival outcomes of patients with hepatocellular carcinoma]. Nan Fang Yi Ke Da Xue Xue Bao 2020;40:567-72. [PMID: 32895140 DOI: 10.12122/j.issn.1673-4254.2020.04.19] [Reference Citation Analysis]
14 Chen Q, Zhang J, Zheng T, Chen H, Nie H, Zheng B, Gong Q. The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in schistosomiasis. Parasit Vectors 2019;12:611. [PMID: 31888743 DOI: 10.1186/s13071-019-3866-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
15 Niu Y, Tang G. miR-185-5p targets ROCK2 and inhibits cell migration and invasion of hepatocellular carcinoma. Oncol Lett 2019;17:5087-93. [PMID: 31105794 DOI: 10.3892/ol.2019.10144] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
16 Martinez-Sanchez A, Nguyen-Tu MS, Cebola I, Yavari A, Marchetti P, Piemonti L, de Koning E, Shapiro AMJ, Johnson P, Sakamoto K, Smith DM, Leclerc I, Ashrafian H, Ferrer J, Rutter GA. MiR-184 expression is regulated by AMPK in pancreatic islets. FASEB J 2018;32:2587-600. [PMID: 29269398 DOI: 10.1096/fj.201701100R] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
17 Wang Z, Ren D, Zheng P. The role of Rho/ROCK in epileptic seizure-related neuronal damage. Metab Brain Dis 2022. [PMID: 35119588 DOI: 10.1007/s11011-022-00909-6] [Reference Citation Analysis]
18 Li S, Yang Y, Shi MH, Wang JF, Ran XQ. miR-96-5p attenuates malathion-induced apoptosis of human kidney cells by targeting the ER stress marker DDIT3. J Environ Sci Health B 2020;55:1080-6. [PMID: 32897819 DOI: 10.1080/03601234.2020.1816092] [Reference Citation Analysis]
19 Yin X, Chai Z, Sun X, Chen J, Wu X, Yang L, Zhou X, Liu F. Overexpression of microRNA-96 is associated with poor prognosis and promotes proliferation, migration and invasion in cholangiocarcinoma cells via MTSS1. Exp Ther Med 2020;19:2757-65. [PMID: 32256758 DOI: 10.3892/etm.2020.8502] [Reference Citation Analysis]
20 Lu Q, Guo Q, Xin M, Lim C, Gamero AM, Gerhard GS, Yang L. LncRNA TP53TG1 Promotes the Growth and Migration of Hepatocellular Carcinoma Cells via Activation of ERK Signaling. Noncoding RNA 2021;7:52. [PMID: 34564314 DOI: 10.3390/ncrna7030052] [Reference Citation Analysis]
21 Wang J, Dong G, Chi W, Nie Y. MiR-96 promotes myocardial infarction-induced apoptosis by targeting XIAP. Biomed Pharmacother 2021;138:111208. [PMID: 33752931 DOI: 10.1016/j.biopha.2020.111208] [Reference Citation Analysis]
22 Luo X, Ji X, Xie M, Zhang T, Wang Y, Sun M, Huang W, Xia L. Advance of SOX Transcription Factors in Hepatocellular Carcinoma: From Role, Tumor Immune Relevance to Targeted Therapy. Cancers (Basel) 2022;14:1165. [PMID: 35267473 DOI: 10.3390/cancers14051165] [Reference Citation Analysis]
23 Lv L, Zhou M, Zhang J, Liu F, Qi L, Zhang S, Bi Y, Yu Y. SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21CIPI , cyclin D1 and β-catenin. FEBS Open Bio 2020;10:135-46. [PMID: 31729835 DOI: 10.1002/2211-5463.12762] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]